1. Home
  2. XNCR vs SCHL Comparison

XNCR vs SCHL Comparison

Compare XNCR & SCHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XNCR
  • SCHL
  • Stock Information
  • Founded
  • XNCR 1997
  • SCHL 1920
  • Country
  • XNCR United States
  • SCHL United States
  • Employees
  • XNCR N/A
  • SCHL N/A
  • Industry
  • XNCR Biotechnology: Pharmaceutical Preparations
  • SCHL Books
  • Sector
  • XNCR Health Care
  • SCHL Consumer Discretionary
  • Exchange
  • XNCR Nasdaq
  • SCHL Nasdaq
  • Market Cap
  • XNCR 547.8M
  • SCHL 644.1M
  • IPO Year
  • XNCR 2013
  • SCHL 1987
  • Fundamental
  • Price
  • XNCR $11.79
  • SCHL $28.68
  • Analyst Decision
  • XNCR Buy
  • SCHL Strong Buy
  • Analyst Count
  • XNCR 11
  • SCHL 1
  • Target Price
  • XNCR $22.20
  • SCHL $37.00
  • AVG Volume (30 Days)
  • XNCR 1.2M
  • SCHL 473.6K
  • Earning Date
  • XNCR 11-05-2025
  • SCHL 09-18-2025
  • Dividend Yield
  • XNCR N/A
  • SCHL 2.79%
  • EPS Growth
  • XNCR N/A
  • SCHL N/A
  • EPS
  • XNCR N/A
  • SCHL N/A
  • Revenue
  • XNCR $146,929,000.00
  • SCHL $1,613,900,000.00
  • Revenue This Year
  • XNCR $23.31
  • SCHL $4.21
  • Revenue Next Year
  • XNCR N/A
  • SCHL $4.13
  • P/E Ratio
  • XNCR N/A
  • SCHL N/A
  • Revenue Growth
  • XNCR N/A
  • SCHL 0.97
  • 52 Week Low
  • XNCR $6.92
  • SCHL $15.77
  • 52 Week High
  • XNCR $27.24
  • SCHL $29.59
  • Technical
  • Relative Strength Index (RSI)
  • XNCR 80.95
  • SCHL 62.25
  • Support Level
  • XNCR $10.24
  • SCHL $26.65
  • Resistance Level
  • XNCR $10.66
  • SCHL $29.59
  • Average True Range (ATR)
  • XNCR 0.61
  • SCHL 1.21
  • MACD
  • XNCR 0.14
  • SCHL 0.19
  • Stochastic Oscillator
  • XNCR 79.71
  • SCHL 86.81

About XNCR Xencor Inc.

Xencor Inc a clinical-stage biopharmaceutical company focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases. The company uses its XmAb technology platform to create antibody product candidates. Its pipeline includes XmAb819, XmAb541, XmAb808, XmAb942, Plamotamab, and XmAb657. The group earns its revenue from collaboration agreements, product licensing agreements, and technology licensing agreements.

About SCHL Scholastic Corporation

Scholastic Corp is an American publishing and education media company that focuses on books and educational material for schools, teachers, parents, and children. It creates print, digital, and audiobooks, learning materials and programs, classroom magazines, and other products that support children's learning and reading both at home and at school. The company also owns rights to various books, including Harry Potter, Dog Man, and The Hunger Games among others. It has three reportable segments Children's Book Publishing and Distribution, Education Solutions, and International. The majority of its revenue is from the Children's Book Publishing and Distribution segment.

Share on Social Networks: